Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
RXRX•Amendment to master agreement with Tempus
Sept 21 (Reuters) - Recursion Pharmaceuticals, Inc. RXRX.O:
RXRX•RXRX•RXRX•Sept 21 (Reuters) - Recursion Pharmaceuticals, Inc. RXRX.O:
